- Home
- LI vs FMS Comparison
LI vs FMS Comparison
Compare LI & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | FMS |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | China | Germany |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.5B |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | LI | FMS |
|---|---|---|
| Price | $11.20 | $22.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 24 | 7 |
| Target Price | $14.98 | ★ $23.72 |
| AVG Volume (30 Days) | ★ 2.5M | 1.2M |
| Earning Date | 11-25-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.68% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.54 | N/A |
| Revenue Next Year | $25.18 | $3.49 |
| P/E Ratio | $29.50 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.67 | $20.02 |
| 52 Week High | $20.95 | $26.95 |
Technical Indicators
Market Signals| Indicator | LI | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 59.25 |
| Support Level | $10.67 | $21.89 |
| Resistance Level | $11.95 | $23.18 |
| Average True Range (ATR) | 0.28 | 0.39 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 17.24 | 99.03 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.